RxDoctor Payments Data

Franklin Zieve

Internal Medicine · Richmond, VANPI 1538195060

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $823 of the $1,174 with a category attached, or 70.1%. Novo Nordisk AS accounts for 99.9% of it on its own, with 1 other manufacturer making up the rest.

$1,174in general payments, 2019–2025

Across 5 payments — averaging $234.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$1K
  • Travere Therapeutics, Inc.$1
$338,542in research payments, 2019–2025

Across 158 payments — averaging $2142.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Kowa Research Institute, Inc.$152K
  • Sanofi US Services Inc.$132K
  • Novo Nordisk AS$28K
  • AstraZeneca$15K
  • Eli Lilly$6K
  • Lexicon Pharmaceuticals, Inc.$3K
  • plus $3K from 3 others

What the payments were for

  • Travel & lodging$82370%
  • Food & beverage$35030%
  • Education$10%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk AS4$1,173
Travere Therapeutics, Inc.1$1

How this compares

$1,174 in reported general payments places this provider in the 80th percentile of 2,724 internal medicine providers in Virginia.

See all internal medicine providers in Virginia

Other internal medicine in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →